(Q40449347)

20 September 2017

Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients. (English)

1 reference

20 September 2017

1 reference

Eiichi Ishikawa

1

1 reference

20 September 2017

Koji Tsuboi

2

1 reference

20 September 2017

Tetsuya Yamamoto

3

1 reference

20 September 2017

Ai Muroi

4

1 reference

20 September 2017

Shingo Takano

5

1 reference

20 September 2017

Takao Enomoto

6

1 reference

20 September 2017

Akira Matsumura

7

1 reference

20 September 2017

Tadao Ohno

8

1 reference

20 September 2017

22 May 2007

1 reference

20 September 2017

1 reference

20 September 2017

98

1 reference

20 September 2017

8

1 reference

20 September 2017

1226-1233

1 reference

Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Autologous cancer vaccine: a novel formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Autologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

Potentiation of a tumor cell susceptibility to autologous CTL killing by restoration of wild-type p53 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00518.X

10.1111/J.1349-7006.2007.00518.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference